Clinical Outcomes of Early Repatriation for Patients With ST-Segment Elevation Myocardial Infarction: A

Wael Abuzeid1, Maria Bennell2, Feng Qiu3

  • 1Schulich Heart Center, Sunnybrook Health Sciences Center, Division of Cardiology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Insights

Early transfer of ST-elevation myocardial infarction (STEMI) patients after PCI to non-PCI centers increases readmission for myocardial infarction (MI). Further research is needed to assess the safety of this early repatriation strategy.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Hospital resource limitations often necessitate early repatriation of ST-elevation myocardial infarction (STEMI) patients post-primary percutaneous coronary intervention (PCI) to non-PCI centers.
  • The safety and implications of this early transfer strategy remain incompletely understood.
  • This study addresses the clinical safety of repatriating STEMI patients to non-PCI facilities after successful PCI.

Purpose of the Study:

  • To evaluate the safety of early patient repatriation from PCI centers to non-PCI centers for STEMI patients.
  • To compare the outcomes of STEMI patients repatriated early versus those remaining at the PCI center.

Main Methods:

  • A cohort of STEMI patients undergoing primary PCI between 2010-2012 was identified.
  • Patients with shock or early mortality were excluded; propensity score matching was used to compare repatriated and non-repatriated groups.
  • One-year all-cause mortality and readmission for recurrent myocardial infarction (MI) were the primary outcomes assessed.

Main Results:

  • 430 well-matched pairs of STEMI patients were analyzed.
  • No significant difference in 1-year all-cause mortality was observed between repatriated and non-repatriated groups (6.7% vs. 5.6%).
  • However, the 1-year readmission rate for MI was significantly higher in the repatriated group (12.1%) compared to the non-repatriated group (5.8%).

Conclusions:

  • Early repatriation of STEMI patients after primary PCI to non-PCI centers is associated with a significantly increased risk of readmission for myocardial infarction.
  • This finding raises concerns about the safety of early repatriation strategies.
  • Further investigation is warranted to fully understand the implications and optimize care pathways for STEMI patients transferred from PCI centers.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
485
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
461
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
327
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
778
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
337